News
11-24-2008, 10:00 AM
Roche Holding AG, the world's largest maker of cancer drugs, saidon Monday that Avastin, generically know as bevacizumab, met itsprimary endpoint in a phase III breast cancer trial.
More... (http://www.healthcentral.com/breast-cancer/news-276441-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-276441-66.html)